IP Library Granted Patent US 10,086,009
Granted Patent B2
US 10,086,009 · App. 11/920,915 · Granted Oct 2, 2018

Compositions containing pufa and/or uridine and methods of use thereof

Inventors: Richard J. Wurtman (Boston, MA); Ingrid Richardson (Newton, MA)
Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGIES
A61K31/7072A61K31/14A61K31/202
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,086,009
App. No.
11/920,915
Granted
Oct 2, 2018
Kind
B2
Abstract

This invention provides methods of enhancing brain development; increasing or enhancing intelligence; increasing or enhancing synthesis and levels of phospholipids, synapses, synaptic proteins, and synaptic membranes by a neural cell or brain cell, comprising contacting a subject or a pregnant or nursing mother thereof with a composition comprising an omega-3 fatty acid, an omega-6 fatty acid, and/or uridine, a metabolic precursor thereof, or a combination thereof.

Claims (19)

1. A method of improving a cognitive function in a subject in need thereof comprising administering to said subject a composition comprising:

(a) an omega-3 fatty acid, an omega-6 fatty acid, or a combination thereof, (b) uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline, and (c) a choline salt,

wherein the uridine phosphate is a uridine-5′-monophosphate (UMP), uridine-5′-diphosphate (UDP), uridine-5′-triphosphate (UTP), or is a salt of the UMP, UDP or UTP; and

wherein the composition has about 200 mg to 800 mg of uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline and about 200 mg to 800 mg of the choline salt and the composition is administered in a therapeutically effective amount to improve cognitive function in the subject and the subject has no cognitive impairment or memory disorder.

2. The method of claim 1 , wherein said omega-3 fatty acid is selected from the group consisting of docosahexaenoic acid, eicosapentaenoic acid, alpha-linolenic acid and a combination thereof, and said omega-6 fatty acid is selected from the group consisting of arachidonic acid, linoleic acid and a combination thereof.

3. The method of claim 1 , wherein the choline salt is choline chloride, choline bitartrate or choline stearate.

4. The method of claim 1 , wherein the composition comprises uridine-5′-monophosphate (UMP), a choline salt and docosahexaenoic acid.

5. The method of claim 1 , wherein the subject is an infant, a toddler, a child or an aging adult.

6. The method of claim 1 , wherein the composition is a medicament or nutritional supplement.

7. The method of claim 1 , wherein the composition is an infant formula.

8. A method of improving or enhancing the intelligence of a subject in need thereof comprising administering to said subject a composition comprising:

(a) an omega-3 fatty acid, an omega-6 fatty acid, or a combination thereof, and (b) uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline, and/or (c) a choline salt, wherein the choline salt is choline chloride, choline bitartrate or choline stearate, and the composition has about 200 mg to 800 mg of uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline and about 200 mg to 800 mg of the choline salt.

9. The method of claim 8 , wherein said omega-3 fatty acid is selected from the group consisting of docosahexaenoic acid, eicosapentaenoic acid, alpha-linolenic acid and a combination thereof, and said omega-6 fatty acid is selected from the group consisting of arachidonic acid, linoleic acid and a combination thereof.

10. The method of claim 8 , wherein said uridine phosphate is a uridine-5′-monophosphate (UMP), uridine-5′-diphosphate (UDP), uridine-5′-triphosphate (UTP), or is a salt of said UMP, UDP or UTP.

11. The method of claim 8 , wherein improving or enhancing the intelligence of a subject comprises improving or enhancing brain development, mental skills, IQ, verbal IQ or verbal intelligence, hearing, practical reasoning, problem solving, school performance, learning, attention, reading skills, writing skills, memory, motor function, social development and/or behavior, emotional development, habituation, cognitive function, cognitive development, mental well being or hand-eye coordination.

12. The method of claim 8 , wherein improving or enhancing the intelligence of a subject comprises reducing problem behavior, internalizing behavior, anxiety, depression, withdrawal, attention problems, hyperactivity, ADHD, social problems, thought problems, externalizing behavior, aggressive behavior, rule-breaking behavior, dyslexia, dyspraxia, or developmental coordination disorder.

13. The method of claim 8 , wherein the subject is an infant, a toddler, a child or an aging adult.

14. The method according to claim 1 , wherein the subject is an adult.

15. The method according to claim 8 , wherein the subject is an adult.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 26, 2012
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029043/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2009
From: WURTMAN, DICK; RICHARDSON, INGRID
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGIES
Reel/Frame 023006/0976 →
Continuity (5)
Provisional Application 60761753 · Jan 25, 2006
Provisional Application 60755058 · Jan 3, 2006
Provisional Application 60716077 · Sep 13, 2005
Provisional Application 60683352 · May 23, 2005
Related Publication 20100022567A1 · Jan 28, 2010